Floatz logo

17 assets in Atherosclerosis

Therapeutic assets addressing Atherosclerosis, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Aspirin
Atherosclerosis
Rajaie Cardiovascular Medical and Research CenterP4BBB (76)
Atorvastatin
Atherosclerosis
Erasmus Medical CenterP4BB (69)
Clopidogrel
Atherosclerosis
Ewha Womans University Seoul HospitalP4BB (68)
Immunoglobulin G1 (256-Tyrosine,258-Threonine,260-Glutamic Acid), Anti-(Neural Apoptosis-Regulated Proteinase 1) (Human-Mus Musculus Monoclonal Hrp00130 .Gamma.1-Chain), Disulfide With (3-Valine,5-Serine,49-Serine,66-Aspartic Acid) Human-Mus Musculus Monoclonal Hrp00130 .Kappa.-Chain, Dimer
Atherosclerosis
Peking Union Medical College HospitalP4BB (65)
Rucacuzumab
Atherosclerosis
Peking Union Medical College HospitalP4BB (65)
Semaglutide
Atherosclerosis
Canadian Medical and Surgical Knowledge Translation Research GroupP4BB (65)
Colchicinum
Atherosclerosis
University College DublinP3BB (64)
Ticagrelor
Atherosclerosis
Assistance Publique - Hôpitaux de ParisP3B (60)
Tocilizumab
Atherosclerosis
Zhujiang HospitalP3B (60)
Physiologic Sodium Chloride Solution
Atherosclerosis
Zhujiang HospitalP3B (58)
Bempedoic Acid
Atherosclerosis
Priscilla Hsue, MDP2CCC (53)
Sarpogrelate
Atherosclerosis
Ewha Womans University Seoul HospitalN/AD (30)
[18F]AlF-OC
Atherosclerosis
Universitaire Ziekenhuizen KU LeuvenP2NR ()